APA (7th ed.) Citation

CS, H., KA, S., S, K., J, C., GS, C., LE, W., . . . CC, D. (2024). Cyclophosphamide and Thiotepa Increases Risk of Transplant-Associated Thrombotic Microangiopathy. Transplantation and cellular therapy, 30(9), 931.e1-931.e10. https://doi.org/10.1016/j.jtct.2024.06.020

Chicago Style (17th ed.) Citation

CS, Higham, et al. "Cyclophosphamide and Thiotepa Increases Risk of Transplant-Associated Thrombotic Microangiopathy." Transplantation and Cellular Therapy 30, no. 9 (2024): 931.e1-931.e10. https://doi.org/10.1016/j.jtct.2024.06.020.

MLA (9th ed.) Citation

CS, Higham, et al. "Cyclophosphamide and Thiotepa Increases Risk of Transplant-Associated Thrombotic Microangiopathy." Transplantation and Cellular Therapy, vol. 30, no. 9, 2024, pp. 931.e1-931.e10, https://doi.org/10.1016/j.jtct.2024.06.020.